» Articles » PMID: 31995555

Application of Non-invasive Low-intensity Pulsed Electric Field with Thermal Cycling-hyperthermia for Synergistically Enhanced Anticancer Effect of Chlorogenic Acid on PANC-1 Cells

Overview
Journal PLoS One
Date 2020 Jan 30
PMID 31995555
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Most existing cancer treatments involve high-cost chemotherapy and radiotherapy, with major side effects, prompting effort to develop alternative treatment modalities. It was reported that the combination of thermal-cycling hyperthermia (TC-HT) and phenolic compound exhibited a moderate cytotoxic effect against human pancreatic cancer PANC-1 cells. In this study, we investigate the efficacy of triple combination in PANC-1 cancer cells by adopting low-intensity pulsed electric field (LIPEF) to couple with TC-HT and CGA (chlorogenic acid). The study finds that this triple combination can significantly impede the proliferation of PANC-1 cells, with only about 20% viable cells left after 24h, whereas being non-toxic to normal cells. The synergistic activity against the PANC-1 cells was achieved by inducing G2/M phase arrest and apoptosis, which were associated with up-regulation of p53 and coupled with increased expression of downstream proteins p21 and Bax. Further mechanism investigations revealed that the cytotoxic activity could be related to mitochondrial apoptosis, characterized by the reduced level of Bcl-2, mitochondrial dysfunction, and sequential activation of caspase-9 and PARP. Also, we found that the triple treatment led to the increase of intracellular reactive oxygen species (ROS) production. Notably, the triple treatment-induced cytotoxic effects and the elevated expression of p53 and p21 proteins as well as the increased Bax/Bcl-2 ratio, all could be alleviated by the ROS scavenger, N-acetyl-cysteine (NAC). These findings indicate that the combination of CGA, TC-HT, and LIPEF may be a promising modality for cancer treatment, as it can induce p53-dependent cell cycle arrest and apoptosis through accumulation of ROS in PANC-1 cells.

Citing Articles

Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications.

Ceylan F, Gunal-Koroglu D, Saricaoglu B, Ozkan G, Capanoglu E, Calina D Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):469-495.

PMID: 39212736 DOI: 10.1007/s00210-024-03396-x.


Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials.

Nguyen V, Taine E, Meng D, Cui T, Tan W Nutrients. 2024; 16(7).

PMID: 38612964 PMC: 11013850. DOI: 10.3390/nu16070924.


Transcriptional Regulation of the Colorectal Cancer Stem Cell Markers, , Induced by a Thermodynamic-Based Therapy Approach.

Ghorbani Z, Heidari M, Jafarinia M, Rohani M, Akbari A Iran J Public Health. 2023; 52(4):848-856.

PMID: 37551178 PMC: 10404326. DOI: 10.18502/ijph.v52i4.12458.


Protection of high-frequency low-intensity pulsed electric fields and brain-derived neurotrophic factor for SH-SY5Y cells against hydrogen peroxide-induced cell damage.

Lin G, Chen W, Kuo Y, Chen Y, Liu H, Chao C Medicine (Baltimore). 2023; 102(31):e34460.

PMID: 37543811 PMC: 10403004. DOI: 10.1097/MD.0000000000034460.


Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells.

Kuo Y, Chen W, Lin G, Lu C, Chao C Aging (Albany NY). 2023; 15(15):7496-7512.

PMID: 37506229 PMC: 10457055. DOI: 10.18632/aging.204916.

References
1.
Antov Y, Barbul A, Mantsur H, Korenstein R . Electroendocytosis: exposure of cells to pulsed low electric fields enhances adsorption and uptake of macromolecules. Biophys J. 2004; 88(3):2206-23. PMC: 1305271. DOI: 10.1529/biophysj.104.051268. View

2.
Hoeferlin L, Oleinik N, Krupenko N, Krupenko S . Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer. 2012; 2(9):889-99. PMC: 3352155. DOI: 10.1177/1947601911432495. View

3.
Hottinger A, Pacheco P, Stupp R . Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro Oncol. 2016; 18(10):1338-49. PMC: 5035531. DOI: 10.1093/neuonc/now182. View

4.
Bayat Mokhtari R, Homayouni T, Baluch N, Morgatskaya E, Kumar S, Das B . Combination therapy in combating cancer. Oncotarget. 2017; 8(23):38022-38043. PMC: 5514969. DOI: 10.18632/oncotarget.16723. View

5.
Liu B, Chen Y, St Clair D . ROS and p53: a versatile partnership. Free Radic Biol Med. 2008; 44(8):1529-35. PMC: 2359898. DOI: 10.1016/j.freeradbiomed.2008.01.011. View